Global X Management Company’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$6.94M Sell
292,300
-644
-0.2% -$13.7K 0.12% 197
2018
Q1
$5.43M Buy
292,944
+44,692
+18% +$661K 0.11% 212
2017
Q4
$3.56M Buy
248,252
+89,448
+56% +$1.16M 0.08% 212
2017
Q3
$1.94M Buy
158,804
+36,740
+30% +$649K 0.05% 247
2017
Q2
$2.23M Buy
122,064
+30,352
+33% +$561K 0.07% 226
2017
Q1
$1.94M Buy
91,712
+69,612
+315% +$1.36M 0.07% 224
2016
Q4
$330K Buy
22,100
+14,500
+191% +$257K 0.01% 493
2016
Q3
$167K Buy
7,600
+4,128
+119% +$91.9K 0.01% 628
2016
Q2
$69K Buy
+3,472
New +$59.1K ﹤0.01% 622

Other funds holding DXCM

Global X Management Company's DXCM Position: Q2 2018 in Review

Global X Management Company reduced its DexCom (DXCM) stake by 0.22% in Q2 2018, selling an estimated $13.7K and leaving 292,300 shares worth $6.94M. The position accounts for 0.12% of the portfolio, ranked #197.

Global X Management Company first reported a position in DXCM in Q2 2016 and has held it in 9 quarters since. 290 funds tracked by Wall St. Rank hold DXCM as of Q2 2018.

  • Global X Management Company held 292,300 shares of DexCom worth $6.94M as of Q2 2018.
  • Global X Management Company sold 644 DexCom shares in Q2 2018, an estimated $13.7K.
  • DexCom made up 0.12% of Global X Management Company's portfolio in Q2 2018, its #197 holding.
  • Global X Management Company first reported a position in DexCom in Q2 2016 and has held it in 9 quarters since.
  • 290 funds tracked by Wall St. Rank held DexCom as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.